Phibro Animal Health (PAHC)
Phibro Animal Health on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
1.0M
Short interest
settlement 2026-10-15
4.3
Days to cover
+0.3 days vs prior
27.7%
Short share of volume
2026-11-02
5,065
Fails to deliver
settlement 2026-10-09
Wed 4 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in PAHC is 1,032,599 shares, down 109,619 shares over the last month. Over the last 48 readings it ranged from 404,721 shares (31 October 2024) to 1,246,682 shares (15 April 2026). At the reported average volume of 239K shares a day that is 4.3 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/pahc" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 1,032,599 | +1.1% | 239,451 | 4.31 |
| 2026-09-30 | 1,020,961 | -10.6% | 251,629 | 4.06 |
| 2026-09-15 | 1,142,218 | -5.5% | 233,563 | 4.89 |
| 2026-08-31 | 1,208,718 | -2.0% | 246,761 | 4.90 |
| 2026-08-14 | 1,233,227 | +3.3% | 169,708 | 7.27 |
| 2026-07-31 | 1,193,479 | -2.0% | 212,386 | 5.62 |
| 2026-07-15 | 1,218,445 | +0.1% | 320,282 | 3.80 |
| 2026-06-30 | 1,217,323 | -1.0% | 287,446 | 4.23 |
| 2026-06-15 | 1,229,844 | +11.6% | 355,556 | 3.46 |
| 2026-05-29 | 1,101,911 | -6.5% | 357,582 | 3.08 |
| 2026-05-15 | 1,179,063 | -3.0% | 584,068 | 2.02 |
| 2026-04-30 | 1,215,037 | -2.5% | 236,559 | 5.14 |
| 2026-04-15 | 1,246,682 | +6.7% | 284,743 | 4.38 |
| 2026-03-31 | 1,168,777 | -2.5% | 351,754 | 3.32 |
| 2026-03-13 | 1,198,831 | +10.3% | 254,274 | 4.71 |
| 2026-02-27 | 1,086,791 | +1.5% | 219,975 | 4.94 |
| 2026-02-13 | 1,070,396 | +1.5% | 406,397 | 2.63 |
| 2026-01-30 | 1,054,464 | -1.2% | 185,119 | 5.70 |
| 2026-01-15 | 1,067,217 | +11.8% | 193,166 | 5.52 |
| 2025-12-31 | 954,331 | +5.2% | 284,606 | 3.35 |
| 2025-12-15 | 907,186 | +1.8% | 279,383 | 3.25 |
| 2025-11-28 | 891,226 | -3.0% | 309,756 | 2.88 |
| 2025-11-14 | 919,138 | -1.1% | 374,185 | 2.46 |
| 2025-10-31 | 929,598 | -3.8% | 251,796 | 3.69 |
| 2025-10-15 | 966,217 | +10.6% | 229,922 | 4.20 |
| 2025-09-30 | 873,352 | +3.8% | 285,456 | 3.06 |
| 2025-09-15 | 841,577 | -9.6% | 411,628 | 2.04 |
| 2025-08-29 | 931,181 | -15.1% | 388,378 | 2.40 |
| 2025-08-15 | 1,097,266 | +7.2% | 262,539 | 4.18 |
| 2025-07-31 | 1,023,596 | +23.1% | 262,734 | 3.90 |
| 2025-07-15 | 831,278 | -12.2% | 379,064 | 2.19 |
| 2025-06-30 | 946,572 | -4.6% | 302,448 | 3.13 |
| 2025-06-13 | 992,497 | +9.4% | 188,814 | 5.26 |
| 2025-05-30 | 907,431 | -3.3% | 251,682 | 3.61 |
| 2025-05-15 | 937,946 | +2.8% | 300,135 | 3.13 |
| 2025-04-30 | 912,469 | +4.6% | 179,776 | 5.08 |
| 2025-04-15 | 872,692 | +2.9% | 238,218 | 3.66 |
| 2025-03-31 | 848,237 | +16.8% | 201,711 | 4.21 |
| 2025-03-14 | 725,995 | -23.1% | 361,919 | 2.01 |
| 2025-02-28 | 943,799 | +8.4% | 322,228 | 2.93 |
| 2025-02-14 | 870,527 | +13.6% | 322,906 | 2.70 |
| 2025-01-31 | 766,458 | -5.3% | 136,562 | 5.61 |
| 2025-01-15 | 809,078 | +6.8% | 148,968 | 5.43 |
| 2024-12-31 | 757,455 | -1.7% | 222,231 | 3.41 |
| 2024-12-13 | 770,806 | +17.7% | 139,987 | 5.51 |
| 2024-11-29 | 654,685 | +41.3% | 170,379 | 3.84 |
| 2024-11-15 | 463,352 | +14.5% | 214,160 | 2.16 |
| 2024-10-31 | 404,721 | +4.5% | 147,591 | 2.74 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of PAHC volume is 27.7%, down 30.7 points over the last five sessions. Over the last 30 readings it ranged from 11.5% (28 September 2026) to 72.8% (30 September 2026). The latest reading is 25.7 points below the 30-session average of 53.4%, on 77K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 21K | 77K | 27.7% | 0 |
| 2026-10-30 | 40K | 55K | 71.9% | 0 |
| 2026-10-29 | 27K | 39K | 67.5% | 0 |
| 2026-10-28 | 37K | 57K | 65.8% | 0 |
| 2026-10-27 | 21K | 36K | 57.7% | 0 |
| 2026-10-26 | 35K | 59K | 58.4% | 838 |
| 2026-10-23 | 21K | 38K | 55.6% | 0 |
| 2026-10-22 | 49K | 105K | 47.1% | 0 |
| 2026-10-21 | 39K | 60K | 64.6% | 0 |
| 2026-10-20 | 29K | 50K | 58.2% | 0 |
| 2026-10-19 | 36K | 69K | 51.3% | 1,644 |
| 2026-10-16 | 28K | 48K | 58.5% | 0 |
| 2026-10-15 | 52K | 82K | 63.1% | 0 |
| 2026-10-14 | 61K | 116K | 52.3% | 0 |
| 2026-10-13 | 67K | 171K | 39.0% | 0 |
| 2026-10-12 | 35K | 89K | 38.9% | 768 |
| 2026-10-09 | 40K | 97K | 41.1% | 0 |
| 2026-10-08 | 36K | 84K | 42.5% | 0 |
| 2026-10-07 | 47K | 72K | 64.5% | 0 |
| 2026-10-06 | 33K | 49K | 65.9% | 0 |
| 2026-10-05 | 44K | 109K | 40.0% | 0 |
| 2026-10-02 | 65K | 99K | 65.8% | 0 |
| 2026-10-01 | 54K | 80K | 67.0% | 0 |
| 2026-09-30 | 41K | 56K | 72.8% | 0 |
| 2026-09-29 | 35K | 54K | 64.3% | 0 |
| 2026-09-28 | 38K | 327K | 11.5% | 0 |
| 2026-09-25 | 42K | 96K | 44.1% | 0 |
| 2026-09-24 | 15K | 43K | 35.9% | 0 |
| 2026-09-23 | 19K | 39K | 48.5% | 0 |
| 2026-09-22 | 25K | 41K | 60.8% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in PAHC is 5,065 shares, up 4,900 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (24 February 2026) to 20,960 shares (15 July 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 5,065 | $37.40 | $189K |
| 2026-09-11 | 165 | $36.58 | $6K |
| 2026-09-08 | 7,972 | $38.25 | $305K |
| 2026-08-12 | 47 | $34.08 | $2K |
| 2026-08-11 | 227 | $34.15 | $8K |
| 2026-08-06 | 99 | $36.01 | $4K |
| 2026-07-22 | 566 | $33.86 | $19K |
| 2026-07-17 | 346 | $34.52 | $12K |
| 2026-07-16 | 51 | $33.74 | $2K |
| 2026-07-15 | 20,960 | $33.04 | $693K |
| 2026-07-14 | 17,766 | $33.00 | $586K |
| 2026-06-15 | 442 | $31.53 | $14K |
| 2026-06-09 | 293 | $31.76 | $9K |
| 2026-06-08 | 263 | $32.43 | $9K |
| 2026-06-05 | 34 | $33.04 | $1K |
| 2026-06-02 | 1,742 | $29.87 | $52K |
| 2026-05-19 | 132 | $34.18 | $5K |
| 2026-05-18 | 169 | $34.37 | $6K |
| 2026-05-08 | 121 | $43.16 | $5K |
| 2026-05-04 | 241 | $54.89 | $13K |
| 2026-05-01 | 1,000 | $53.18 | $53K |
| 2026-04-01 | 28 | $55.31 | $2K |
| 2026-03-25 | 10 | $55.48 | $555 |
| 2026-03-23 | 302 | $50.76 | $15K |
| 2026-03-17 | 200 | $51.17 | $10K |
| 2026-03-04 | 378 | $52.27 | $20K |
| 2026-02-24 | 1 | $51.52 | $52 |
| 2026-02-23 | 98 | $52.80 | $5K |
| 2026-02-20 | 2,266 | $51.85 | $117K |
| 2026-02-10 | 1,640 | $51.85 | $85K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for PAHC in the last 90 days. The most recent filings are listed below. Latest filing: Rodriguez Patrick (VP Finance and Treasurer) on 2026-08-06.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | Rodriguez Patrick | VP Finance and Treasurer | Grant | 2K | $0.00 | $0 | 2K |
| 2026-08-06 | Weinstein Judith | See Remarks | Grant | 2K | $0.00 | $0 | 5K |
| 2026-08-06 | Miller Larry Lee | Chief Operating Officer | Grant | 4K | $0.00 | $0 | 38K |
| 2026-08-06 | Escudero Lisa Ann | See Remarks | Grant | 2K | $0.00 | $0 | 3K |
| 2026-08-06 | David Glenn | Chief Financial Officer | Grant | 3K | $0.00 | $0 | 55K |
| 2026-08-06 | Bendheim Daniel M | President and CEO | Grant | 12K | $0.00 | $0 | 15K |
| 2026-08-06 | BENDHEIM Jonathan | Director | Grant | 3K | $0.00 | $0 | 6K |
| 2026-08-06 | BENDHEIM JACK | Executive Chairman | Grant | 12K | $0.00 | $0 | 27K |
| 2026-08-04 | Weinstein Judith | See Remarks | Other transaction | 472 | $36.60 | $17K | 3K |
| 2026-08-04 | Miller Larry Lee | Chief Operating Officer | Other transaction | 635 | $36.60 | $23K | 35K |
| 2026-08-04 | Escudero Lisa Ann | See Remarks | Other transaction | 265 | $36.60 | $10K | 2K |
| 2026-08-04 | David Glenn | Chief Financial Officer | Other transaction | 840 | $36.60 | $31K | 51K |
| 2026-08-04 | Bendheim Daniel M | President and CEO | Other transaction | 486 | $36.60 | $18K | 3K |
| 2026-08-04 | BENDHEIM JACK | Executive Chairman | Other transaction | 2K | $36.60 | $84K | 15K |
| 2026-05-29 | CORCORAN E THOMAS | Director | Buy | 10K | $31.77 | $318K | 41K |
| 2026-05-07 | BENDHEIM JACK | President and CEO | Sell | 2K | $49.19 | $100K | 56K |
| 2026-05-07 | BENDHEIM JACK | President and CEO | Sell | 1K | $48.31 | $56K | 58K |
| 2026-05-07 | BENDHEIM JACK | President and CEO | Sell | 1K | $47.59 | $64K | 59K |
| 2026-05-06 | BENDHEIM JACK | President and CEO | Sell | 1K | $58.13 | $82K | 61K |
| 2026-05-06 | BENDHEIM JACK | President and CEO | Sell | 6K | $57.18 | $322K | 62K |
| 2026-05-05 | BENDHEIM JACK | President and CEO | Sell | 776 | $56.37 | $44K | 68K |
| 2026-05-05 | BENDHEIM JACK | President and CEO | Sell | 6K | $55.73 | $349K | 68K |
| 2026-04-30 | BENDHEIM JACK | President and CEO | Sell | 1K | $53.32 | $66K | 75K |
| 2026-04-30 | BENDHEIM JACK | President and CEO | Sell | 6K | $52.65 | $306K | 76K |
| 2026-04-29 | BENDHEIM JACK | President and CEO | Sell | 3K | $53.21 | $162K | 82K |
| 2026-04-29 | BENDHEIM JACK | President and CEO | Sell | 4K | $52.70 | $211K | 85K |
| 2026-04-28 | BENDHEIM JACK | President and CEO | Sell | 797 | $56.69 | $45K | 89K |
| 2026-04-28 | BENDHEIM JACK | President and CEO | Sell | 5K | $56.06 | $257K | 90K |
| 2026-04-28 | BENDHEIM JACK | President and CEO | Sell | 2K | $55.10 | $91K | 94K |
| 2026-04-23 | BENDHEIM JACK | President and CEO | Sell | 421 | $54.56 | $23K | 96K |
| 2026-04-23 | BENDHEIM JACK | President and CEO | Sell | 7K | $54.07 | $358K | 96K |
| 2026-04-22 | BENDHEIM JACK | President and CEO | Sell | 7K | $54.29 | $382K | 103K |
| 2026-04-21 | BENDHEIM JACK | President and CEO | Sell | 5K | $56.17 | $304K | 110K |
| 2026-04-21 | BENDHEIM JACK | President and CEO | Sell | 2K | $55.35 | $90K | 115K |
| 2026-04-16 | BFI Co., LLC | TenPercentOwner | Sell | 2K | $54.88 | $102K | 117K |
| 2026-04-16 | BFI Co., LLC | TenPercentOwner | Sell | 5K | $54.56 | $283K | 119K |
| 2026-04-16 | BFI Co., LLC | TenPercentOwner | Conversion | 100K | $0.00 | $0 | 124K |
| 2026-04-16 | BENDHEIM JACK | President and CEO | Sell | 2K | $54.88 | $102K | 117K |
| 2026-04-16 | BENDHEIM JACK | President and CEO | Sell | 5K | $54.56 | $283K | 119K |
| 2026-04-16 | BENDHEIM JACK | President and CEO | Conversion | 100K | $0.00 | $0 | 124K |
| 2026-04-15 | BFI Co., LLC | TenPercentOwner | Sell | 799 | $58.11 | $46K | 24K |
| 2026-04-15 | BFI Co., LLC | TenPercentOwner | Sell | 4K | $57.21 | $207K | 25K |
| 2026-04-15 | BFI Co., LLC | TenPercentOwner | Sell | 3K | $56.27 | $148K | 28K |
| 2026-04-15 | BENDHEIM JACK | President and CEO | Sell | 799 | $58.11 | $46K | 24K |
| 2026-04-15 | BENDHEIM JACK | President and CEO | Sell | 4K | $57.21 | $207K | 25K |
| 2026-04-15 | BENDHEIM JACK | President and CEO | Sell | 3K | $56.27 | $148K | 28K |
| 2026-04-14 | BFI Co., LLC | TenPercentOwner | Sell | 492 | $59.69 | $29K | 31K |
| 2026-04-14 | BFI Co., LLC | TenPercentOwner | Sell | 7K | $59.03 | $387K | 32K |
| 2026-04-14 | BENDHEIM JACK | President and CEO | Sell | 492 | $59.69 | $29K | 31K |
| 2026-04-14 | BENDHEIM JACK | President and CEO | Sell | 7K | $59.03 | $387K | 32K |
| 2026-03-31 | BENDHEIM JACK | President and CEO | Sell | 431 | $54.35 | $23K | 38K |
| 2026-03-31 | BENDHEIM JACK | President and CEO | Sell | 7K | $53.87 | $356K | 39K |
| 2026-03-30 | BENDHEIM JACK | President and CEO | Sell | 617 | $54.31 | $34K | 45K |
| 2026-03-30 | BENDHEIM JACK | President and CEO | Sell | 6K | $53.54 | $344K | 46K |
| 2026-03-26 | BENDHEIM JACK | President and CEO | Sell | 280 | $57.17 | $16K | 52K |
| 2026-03-26 | BENDHEIM JACK | President and CEO | Sell | 7K | $56.79 | $384K | 52K |
| 2026-03-25 | BENDHEIM JACK | President and CEO | Sell | 552 | $56.86 | $31K | 59K |
| 2026-03-25 | BENDHEIM JACK | President and CEO | Sell | 5K | $56.00 | $275K | 60K |
| 2026-03-25 | BENDHEIM JACK | President and CEO | Sell | 2K | $55.28 | $87K | 65K |
| 2026-03-24 | BENDHEIM JACK | President and CEO | Sell | 517 | $53.59 | $28K | 66K |
| 2026-03-24 | BENDHEIM JACK | President and CEO | Sell | 7K | $52.88 | $345K | 67K |
| 2026-03-19 | BENDHEIM JACK | President and CEO | Sell | 124 | $53.24 | $7K | 73K |
| 2026-03-19 | BENDHEIM JACK | President and CEO | Sell | 5K | $52.79 | $263K | 73K |
| 2026-03-19 | BENDHEIM JACK | President and CEO | Sell | 2K | $51.78 | $100K | 78K |
| 2026-03-18 | BENDHEIM JACK | President and CEO | Sell | 3K | $53.64 | $142K | 80K |
| 2026-03-18 | BENDHEIM JACK | President and CEO | Sell | 4K | $53.03 | $191K | 83K |
| 2026-03-18 | BENDHEIM JACK | President and CEO | Sell | 4K | $51.80 | $223K | 87K |
| 2026-03-17 | BENDHEIM JACK | President and CEO | Sell | 5K | $51.66 | $273K | 91K |
| 2026-03-13 | BENDHEIM JACK | President and CEO | Sell | 5K | $48.91 | $258K | 96K |
| 2026-03-12 | BENDHEIM JACK | President and CEO | Conversion | 100K | $0.00 | $0 | 101K |
| 2026-02-26 | BFI Co., LLC | TenPercentOwner | Sell | 6K | $53.67 | $340K | 2K |
| 2026-02-26 | BFI Co., LLC | TenPercentOwner | Sell | 711 | $54.28 | $39K | 1K |
| 2026-02-26 | BENDHEIM JACK | President and CEO | Sell | 711 | $54.28 | $39K | 1K |
| 2026-02-26 | BENDHEIM JACK | President and CEO | Sell | 6K | $53.67 | $340K | 2K |
| 2026-02-25 | BFI Co., LLC | TenPercentOwner | Sell | 7K | $51.71 | $364K | 9K |
| 2026-02-25 | BENDHEIM JACK | President and CEO | Sell | 7K | $51.71 | $364K | 9K |
| 2026-02-24 | BFI Co., LLC | TenPercentOwner | Sell | 1K | $51.88 | $60K | 16K |
| 2026-02-24 | BFI Co., LLC | TenPercentOwner | Sell | 6K | $51.27 | $302K | 17K |
| 2026-02-24 | BENDHEIM JACK | President and CEO | Sell | 1K | $51.88 | $60K | 16K |
| 2026-02-24 | BENDHEIM JACK | President and CEO | Sell | 6K | $51.27 | $302K | 17K |
| 2026-02-20 | BFI Co., LLC | TenPercentOwner | Sell | 397 | $51.96 | $21K | 23K |
| 2026-02-20 | BFI Co., LLC | TenPercentOwner | Sell | 7K | $51.38 | $341K | 23K |
| 2026-02-20 | BENDHEIM JACK | President and CEO | Sell | 397 | $51.96 | $21K | 23K |
| 2026-02-20 | BENDHEIM JACK | President and CEO | Sell | 7K | $51.38 | $341K | 23K |
| 2026-02-19 | BFI Co., LLC | TenPercentOwner | Sell | 7K | $50.26 | $354K | 30K |
| 2026-02-19 | BENDHEIM JACK | President and CEO | Sell | 7K | $50.26 | $354K | 30K |
| 2026-02-18 | BFI Co., LLC | TenPercentOwner | Sell | 7K | $51.38 | $351K | 37K |
| 2026-02-18 | BFI Co., LLC | TenPercentOwner | Sell | 216 | $51.97 | $11K | 37K |
| 2026-02-18 | BENDHEIM JACK | President and CEO | Sell | 216 | $51.97 | $11K | 37K |
| 2026-02-18 | BENDHEIM JACK | President and CEO | Sell | 7K | $51.38 | $351K | 37K |
| 2026-02-13 | BFI Co., LLC | TenPercentOwner | Sell | 7K | $51.96 | $366K | 44K |
| 2026-02-13 | BENDHEIM JACK | President and CEO | Sell | 7K | $51.96 | $366K | 44K |
| 2026-02-11 | David Glenn | Chief Financial Officer | Other transaction | 13K | $51.63 | $647K | 52K |
| 2026-02-11 | BENDHEIM JACK | President and CEO | Sell | 234 | $52.21 | $12K | 51K |
| 2026-02-11 | BENDHEIM JACK | President and CEO | Sell | 14K | $51.61 | $720K | 51K |
| 2026-02-10 | BENDHEIM JACK | President and CEO | Sell | 7K | $52.17 | $366K | 65K |
| 2026-02-10 | BENDHEIM JACK | President and CEO | Sell | 51K | $51.76 | $2.6M | 72K |
| 2026-02-09 | David Glenn | Chief Financial Officer | Exercise or conversion | 30K | price not stated in the filing | not stated | 65K |
| 2026-02-05 | BFI Co., LLC | TenPercentOwner | Sell | 3K | $46.68 | $148K | 227K |
| 2026-02-05 | BFI Co., LLC | TenPercentOwner | Sell | 38K | $47.91 | $1.8M | 188K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON7 Form 144 notices on file for PAHC worth $830K at the prices reported; 0 in the last 90 days worth $0. Latest: Weinstein Judith filed on 2026-08-04 to sell 472 shares ($17K) from 2026-08-04.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-04 | Weinstein JudithOfficer | 472 | $17K | 0.002% | 2026-08-04 | Fidelity Brokerage Services LLC |
| 2026-08-04 | Miller Larry LeeOfficer | 635 | $23K | 0.003% | 2026-08-04 | Fidelity Brokerage Services LLC |
| 2026-08-04 | Escudero Lisa AnnOfficer | 265 | $10K | 0.001% | 2026-08-04 | Fidelity Brokerage Services LLC |
| 2026-08-04 | David GlennOfficer | 840 | $31K | 0.004% | 2026-08-04 | Fidelity Brokerage Services LLC |
| 2026-08-04 | Bendheim Daniel MOfficer, Director | 486 | $18K | 0.002% | 2026-08-04 | Fidelity Brokerage Services LLC |
| 2026-08-04 | BENDHEIM JACKOfficer, Director | 2K | $84K | 0.011% | 2026-08-04 | Fidelity Brokerage Services LLC |
| 2026-02-11 | David GlennOfficer | 13K | $647K | 0.061% | 2026-02-11 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON5 holders report 5% or more of PAHC in their latest filing, 2 on Schedule 13D (active intent). The largest reported stake is BFI Co., LLC at 48.2% of the class (19,552,186 shares), filed 2026-05-22 for an event on 2026-05-20.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-10-19 | 13G/Ano. 1 | Israel A. Englanderindividual | 823K | 3.9% | 2026-09-30 |
| 2026-10-19 | 13G/Ano. 1 | Millennium Group Management LLCother entity | 823K | 3.9% | 2026-09-30 |
| 2026-10-19 | 13G/Ano. 1 | Millennium Management LLCother entity | 823K | 3.9% | 2026-09-30 |
| 2026-08-06 | 13G/Ano. 1 | FMR LLCparent holding company | 3.2M | 15.0% | 2026-06-30 |
| 2026-08-06 | 13G/Ano. 1 | Abigail P. Johnsonindividual | 3.2M | 15.0% | 2026-06-30 |
| 2026-05-22 | 13D/Ano. 25 | BFI Co., LLCparent holding company | 19.6M | 48.2% | 2026-05-20 |
| 2026-05-22 | 13D/Ano. 25 | Jack C. Bendheimindividual | 19.6M | 48.2% | 2026-05-20 |
| 2026-05-14 | 13G/Ano. 1 | Barclays PLCparent holding company | 264K | 1.3% | 2026-03-31 |
| 2026-04-30 | 13G | Vanguard Capital Managementinvestment adviser | 1.0M | 5.1% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 13 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding PAHC at their latest 13F. JSON6 of the 30 tracked managers held PAHC at their latest 13F, $48.4M in total at quarter-end prices. Millennium Management is the largest at $29.4M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 2 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 937K | $29.4M | 0.01% | +881K |
| Renaissance Technologies | 2026-06-30 | 481K | $15.1M | 0.02% | -96K |
| AQR Capital Management | 2026-06-30 | 64K | $2.0M | 0.00% | +7K |
| D. E. Shaw & Co. | 2026-06-30 | 27K | $856K | 0.00% | +19K |
| Two Sigma Investments | 2026-06-30 | 17K | $543K | 0.00% | -4K |
| Citadel Advisors | 2026-06-30 | 15K | $468K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q4 FY 2026 (quarter ended 2026-06-30) Phibro Animal Health reported revenue of $396.7M, up 4.8% from the same quarter a year earlier, and net income of $21.7M. In FY 2026 it generated $69.0M of operating cash flow and spent $19.5M on dividends.
- Cash
- $61.4M
- Equity
- $385.5M
- Total assets
- $1.50B
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q4 FY 2026derived | 2026-06-30 | $396.7M | $21.7M | 5.5% | n/a |
| Q3 FY 2026 | 2026-03-31 | $383.5M | $24.0M | 6.3% | 0.59 |
| Q2 FY 2026 | 2025-12-31 | $373.9M | $27.5M | 7.3% | 0.67 |
| Q1 FY 2026 | 2025-09-30 | $363.9M | $26.5M | 7.3% | 0.65 |
| Q4 FY 2025derived | 2025-06-30 | $378.7M | $17.2M | 4.5% | n/a |
| Q3 FY 2025 | 2025-03-31 | $347.8M | $20.9M | 6.0% | 0.51 |
| Q2 FY 2025 | 2024-12-31 | $309.3M | $3.2M | 1.0% | 0.08 |
| Q1 FY 2025 | 2024-09-30 | $260.4M | $7.0M | 2.7% | 0.17 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $1.52B | $99.7M | $69.0M | n/a | n/a | $19.5M |
| FY 2025 | 2025-06-30 | $1.30B | $48.3M | $80.1M | n/a | n/a | $19.4M |
| FY 2024 | 2024-06-30 | $1.02B | $2.4M | $87.6M | n/a | n/a | $19.4M |
| FY 2023 | 2023-06-30 | $977.9M | $32.6M | $13.3M | n/a | n/a | $19.4M |
| FY 2022 | 2022-06-30 | $942.3M | $49.2M | $31.6M | n/a | n/a | $19.4M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30.
What this page is
Phibro Animal Health in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Phibro Animal Health (PAHC), SEC CIK 1069899, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-04.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-19.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-26.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-08-06.JSON and CSV
- Company record
- EDGAR filing index for CIK 1069899Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
Datasets
Frequently Asked Questions
How much of PAHC is sold short?
1,032,599 shares were held short at the 2026-10-15 settlement, 4.3 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is PAHC's daily short volume?
On 2026-11-02, 21,451 of the 77,339 PAHC shares reported to FINRA were sold short, 27.7% of the day's reported volume. Short volume is a flow for one day, not a position.
Does PAHC have fails to deliver?
The SEC's latest file shows 5,065 PAHC shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are PAHC insiders buying or selling?
No open-market insider trades were reported for PAHC in the last 90 days. The most recent filings are listed below. Latest filing: Rodriguez Patrick (VP Finance and Treasurer) on 2026-08-06.
Have PAHC insiders filed to sell?
7 Form 144 notices on file for PAHC worth $830K at the prices reported; 0 in the last 90 days worth $0. Latest: Weinstein Judith filed on 2026-08-04 to sell 472 shares ($17K) from 2026-08-04.
Who owns 5% or more of PAHC?
5 holders report 5% or more of PAHC in their latest filing, 2 on Schedule 13D (active intent). The largest reported stake is BFI Co., LLC at 48.2% of the class (19,552,186 shares), filed 2026-05-22 for an event on 2026-05-20.
What did PAHC report last quarter?
In Q4 FY 2026 (quarter ended 2026-06-30) Phibro Animal Health reported revenue of $396.7M, up 4.8% from the same quarter a year earlier, and net income of $21.7M. In FY 2026 it generated $69.0M of operating cash flow and spent $19.5M on dividends.
Which tracked 13F managers own PAHC?
6 of the 30 tracked 13F managers held PAHC shares at their latest filing, $48.4M in all. The largest: Izzy Englander's Millennium Management (937K shares, $29.4M), Renaissance Technologies (481K shares, $15.1M), Cliff Asness's AQR Capital Management (64K shares, $2.0M), D. E. Shaw & Co. (27K shares, $856K), Two Sigma Investments (17K shares, $543K), Ken Griffin's Citadel Advisors (15K shares, $468K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.